On September 10, 2025, SonoScape (hereinafter referred to as "SonoScape") and Zhejiang Barty Medical Technology Co., Ltd. (hereinafter referred to as "Barty Medical") officially signed a strategic cooperation agreement in Hangzhou. In response to the growing demand for cardiovascular disease diagnosis and treatment in the Chinese market, the two parties have established a strategic partnership to integrate their respective advantageous resources, focusing on the development and promotion of next-generation interventional technologies represented by "precision diagnosis and treatment" and "intervention without implantation," providing Chinese patients with coronary heart disease more comprehensive and precise treatment options.

Under the joint witness of both parties' representatives, including Wu Kunxiang, President of SonoScape, Feng Baolin, Director of Hangzhou Medical Port Management Office, and Yan Yuqiang, Chairman of Barty Medical, as well as specially invited guests, Zhao Li, Head of Cardiovascular Business at SonoScape, and Hu Chao, General Manager of Zhejiang Barty Medical Technology Co., Ltd., officially signed the Strategic Cooperation Agreement.

Mr. Wu Kunxiang, President of SonoScapeRepresentation"The potential of the vascular intervention market is enormous, with 'precision diagnosis and treatment' and 'intervention without implantation' being clear clinical needs and future technological development directions. Barty Medical possesses a long-standing advantage in lean manufacturing and has achieved remarkable success in the R&D and industrialization of innovative medical devices such as advanced drug-coated technology and restrained balloon technology. This demonstrates its profound expertise and forward-looking strategy in the vascular intervention field, forming a strategic complementarity with SonoScape's strengths in high-end medical devices. The collaboration between both parties is timely and will help us jointly create a complete solution from precise diagnosis to innovative treatment, making domestic brands a true 'blessing' for safeguarding people’s health!"

Mr. Yan Yuqiang, Chairman of Barty Medical, stated"SonoScape's technical strength and market influence in the high-end medical device field are truly admirable. This strategic cooperation not only reflects our high recognition of its deep technological accumulation but also our deep appreciation for its team culture of being 'professional, efficient, pragmatic, and progressive.' The vascular intervention market is encountering unprecedented development opportunities, with patients' demand for 'precise diagnosis and treatment' continuously increasing. We highly value SonoScape's profound expertise in high-end medical imaging and precision diagnostics. Looking ahead, both parties will fully leverage their respective strengths to achieve resource complementarity, bringing more leading international-standard diagnostic and treatment solutions to patients and clinicians, allowing medical technology to illuminate life."

Cardiovascular intervention, as a high-potential field that SonoScape has strategically emphasized, uses intravascular ultrasound (IVUS) as the core breakthrough. With technological advancements and market penetration, it has formed a unique competitive edge. The signing of this strategic cooperation agreement is not only an important milestone in the partnership but also signifies that both parties will collaborate to create an overall solution for cardiovascular intervention, ranging from IVUS imaging to percutaneous coronary intervention (PCI) procedures.

SonoScape and Barty Medical Forge Strategic Partnership for Collaborative Innovation in Cardiovascular Care

About SonoScape

SonoScape (Stock Code: 300633) is a globally leading technology company dedicated to the independent research, development, and manufacturing of medical devices. Its expertise spans fields such as ultrasound medical imaging, endoscopic diagnosis and treatment, minimally invasive surgery, and cardiovascular intervention, providing specialized and comprehensive solutions to medical institutions in over 170 countries and regions worldwide. SonoScape aims to become a technological force safeguarding global health, creating more possibilities for life.